Evotec SE (EVO) Total Liabilities (2009 - 2026)
Evotec SE's (EVO) quarterly Total Liabilities came in at $1.1 billion in Q2 2026, down 3.08% year-over-year from $1.1 billion in Q2 2025, and down 4.07% quarter-over-quarter from $1.1 billion in Q1 2026.
Analysis
Evotec SE (EVO) Total Liabilities (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Total Liabilities across 10 years of filings, most recently posting $1.1 billion for Q2 2026.
- In Q2 2026, Total Liabilities fell 3.08% year-over-year to $1.1 billion; the TTM figure through Jun 2026 stood at $1.1 billion (down 3.08% YoY), while the FY2025 annual figure was $1.0 billion, down 2.11% from the prior year.
- Total Liabilities came in at $1.1 billion for Q2 2026 at Evotec SE, down from $1.1 billion in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $1.2 billion in Q2 2023 to a low of $312195.7 in Q4 2022.
- Average Total Liabilities over 5 years is $916.8 million, with a median of $1.1 billion recorded in 2026.
- Year-over-year, Total Liabilities tumbled 75.26% in 2022 and surged 306467.22% in 2024.
- Over 5 years, Total Liabilities stood at $312195.7 in 2022, then increased by 7.18% to $334617.3 in 2023, then jumped by 306467.22% to $1.0 billion in 2024, then rose by 2.15% to $1.0 billion in 2025, then gained by 0.76% to $1.1 billion in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $1.1 billion in Q2 2026, $1.1 billion in Q1 2026, and $1.0 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 23.58 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 1.62 Bn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 4.64 Bn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 7.02 Bn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 2.19 Bn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | 1.06 Bn |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 569.76 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 22.92 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 7.02 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | 6.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.06 Bn |
| Mar 31, 2026 | 1.10 Bn |
| Dec 31, 2025 | 1.05 Bn |
| Sep 30, 2025 | 1.14 Bn |
| Jun 30, 2025 | 1.09 Bn |
| Mar 31, 2025 | 1.09 Bn |
| Dec 31, 2024 | 1.03 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Dec 31, 2023 | 334,617.31 |
| Jun 30, 2023 | 1.23 Bn |
| Dec 31, 2022 | 312,195.69 |
| Sep 30, 2022 | 1.04 Bn |
| Mar 31, 2022 | 982.23 Mn |
| Dec 31, 2021 | 1.26 Mn |
| Sep 30, 2021 | 914.15 Mn |
| Dec 31, 2020 | 7.61 Mn |
| Dec 31, 2019 | 4.72 Mn |
| Sep 30, 2010 | 59.63 Mn |
| Jun 30, 2010 | 41.96 Mn |
| Mar 31, 2010 | 44,270.56 |